October 26, 2020 Comments Off on New patent for Acacia drug BYFAVO Posted in: Patent Added Annual Drug Patent Expirations for BYFAVO Byfavo is a drug marketed by Acacia and is included in one NDA. The generic ingredient in BYFAVO is remimazolam besylate. Additional details are…
The post New patent for Acacia drug BYFAVO appeared first on Dru…
October 23, 2020 Comments Off on New patent for Celgene drug POMALYST Posted in: Patent Added Annual Drug Patent Expirations for POMALYST Pomalyst is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
The post New patent for Celgene drug POMALYST appeared first on DrugP…